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the pathophysiology of congestive heart failure (CHF), Recently, the im- 
mune system has also been implicated in the progreSSion of CHR There- 
fore, we investigated whether plasma soluble intercellular adhesion molecule 
(slCAM)-I levels are elevated in patients with CHF by means of enzyme- 
linked immunosorbent assay. Furthermore, we assessed whether the plasma 
slCAM-1 ¢oncentraflon could previde supplementary pregnostio information 
in addition to that obtained from standard clinical and I;=~ hemical variables 
previously known to be associated with a high mortality, The plasma concen- 
tration of slCAM+I, atrial nalduretic paptide (ANP), brain natriureflc paptide 
(BNP), and norepineghdne (NE) were measured in 102 patients with CHF 
(left ventdcolar ejection fraction (EF) < 0.45; NYHA class II-IV). The patients 
were then monitored for a follOw-up pedod of over 18 months. The plasma 
alCAM-1 concentxation i creased with the severity of the CHF (normal. 150 
10 ng/ml; NYHA class II, 228 ± 19 ng/ml; NYHA class Ill-IV, 292:1:20 
ng/ml), and there was a significant negative correlation between the plasma 
alCAM-1 concentration and the EF (r = -0.34; p < 0.001). A Cox proportional 
hazard analysis was performed to determine if the plasma levels of slCAM-1, 
ANP, BNP, and NE were the independent significant predictors of the EF. 
High concentrations of slGAM-1 (p = 0+01) and BNP (p = 0.001), but not 
ANP nor NE, were shown to provide be significant independent prognostic 
predictors in 102 CHF patients, 
These findings indicate that the plasma concentration of alCAM-1 is ale- 
vated in CHF and that high plasma levels of slCAM-1 can be independent 
prognosflc predictor in patientS with CHR Taken together, these findings 
suggest that the immune system, as well as neurohumoral activation play a 
significant rote in the pathophysi01ogy and progression of CHF. 
~ T h e  DD of the ACE-Gene Is Associated Genotype 
W'dh Increased Mortal ity in Idiopathic Heart Failure 
Bert Andersson, Christer Sylvan, 
Div, of Cardiology. Wal/enberg Laboratory for Cardiovascular Research, 
Sahlgrenska University Hospital, GOteborg: Div. of Cardiolo~, Dept. of 
Medicine, Karolinska Institute at Huddinge Hospital, Stockholm, Sweden 
An insertion (//}/deletion (D) polymorphism in the angictensin IT-converting 
enzyme (ACE) gene has been associated with increased levels of ACE. To 
relate this polymorphism to survival and cardiac function we investigated a 
group of patients with idiopathic congestive heart fal!~Jre (CHF) (n = 193), 
recruited from the world's largest unselected CHF population (n = 2711). 
DNA from white blood cells Was isolated and the occurrence of an/Tor a D 
allele in the ACE-gane was analysed by PCR technique. The patientS were 
investigated by echocardiography. Five-year survival data was available for 
all patients. 
Results: Patients with genotypa DD {n = 67) 0.6 had a significantly poorer 
survival as compared with the ID///greup (n = 126), as assessed by a Cox 
multivariate regression analysis (p = 0.001), The only difference in cardiac 
function between the two gmupe was an increase in left vantdcular mass in 
the DD group (153 ± 57 vs 134 ± 44 g/m 2; p = 0.02). 
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Conclusion: The DD ganotype of the ACE-gena polymorphism implicated 
an increased mortality in patients with idiopathic CHF. The increase in left 
ventricular mass provides a possible pathophyslolegical link between an 
increased ACE-activity and mortality, 
HEMODYNAMICS/SHOCWASSIST  DEVICES 
~ g s e  of the Intre.aortic Bal loon Pump as an Aort ic 
Cross-clamp to Maximize Effectiveness of CPR in 
Humans 
Roger H. Coletti, Bruce J. Haik, Joseph G. Wiedermann. Hackensack 
Medical Center, Hackensack, NJ 
Experimental data in the dog model has suggested that coronary blood 
flow during cardiopulmonary resuscitation (CPR) is markedly augmented by 
abdominal aortic cro~-clamping. In an attempt o apply this data to CPR in 
humans, we have developed a novel use Of the intra-aortic balloon pump 
(IABP), which allows it to work as a functional aortic cross-clamp. Using a 
conventional recent-modal DataScope TM IABP, settings of "1" on the inflation 
cycle and "4" on the deflation cycle are selected, The IABP is then set to 
"internal trigger" at 1:1, with the ECG disconnected. These settings will keep 
the IABP inflated almost constantly, allowing a brief deflated period for limb 
peffusion while maximizing coronary blood flow. 
This IABP strategy was used in 7 consecutive patients (over a 1 year 
period) who suffered cardiac arrest requiting CPR while undergoing coro- 
nary intervention, and failed to respond to conventional balloon-pumping+ All 
7 patientS experienced cardiac arrest (non,arrhythmic) secondary to acute 
closure of a major epicardiat vessel, with no immediate response to prompt 
re.opening of the culprit vessel, and nO significant hemodynamic improve- 
ment with conventional use of the IABP for >_ 5 rain. All 7 patients displayed 
ST elevations _> 3 mm in the distribution of the culprit artery. After document- 
ing absence of hemodynamic imp.,ovemant despite standard ACtS protocol, 
CPR, and ~ 5 rain. of conventional IABP use, the IABP was set to cress- 
clamp mode and CPR was continued, All 7 patients exhibited no,--realization 
of ST segments and restoration of hemodynamlc stability within 8 minutes of 
combined application of IABP cross-clamp and CPR with manual compres- 
sion. All seven patients were safely discharged from the hospital within 10 
days post-precadure+ 
Conclusions: IABP settings oan be modified in such a way as to allow 
the balloon pump to act as a functional aortic cross-clamp. Use of this 
novel IABP cress-clamp technique can maximize the effectiveness Of CPR 
during cardiac arrest, presumably by augmenting coronary blood flow. IABP 
cross-clamp can produce patient salvage even after the failure of standard 
ACLS/CPR protocols combined with conventional balloon-pumping. Use of 
the IABP cress-clamp technique is prebabty of greatest benefit in cases 
of cardiac arrest secondary to corenary flow obstruction, such as in acute 
closure during percutaneous coronary lnte,'ventions 
~ Systemic Capi l lary Leak Syndrome, Long-Term 
Fol low I,/~ 
Naeem K. Tahirkheli, Philip R. Greipp. Mayo Clinic, Rochester, MN 
Systemic Capillary Leak Syndrome (SCLS) is a rare idiopathic disorder, char* 
aCtedzed by hypotension, hemoconcentration and marked shifts of plasma 
(t0-7(P/=) from intravascular to extravasoular space. A monoclonal gem+ 
mopathy is almost always found. Complications include anasarce, compart- 
ment syndromes resulting in rhabdomyolysis, myocardial infamtion, hypov- 
olemic shock, renal shut-down and frequently death. We reported our initial 
successful experience with a combination of terbutaline and aminophylline. 
We now report further follow up on this regimen in a larger cohort. 
Methods: 7 patients of SCLS were seen at Mayo Clinic in the last 15 years, 
ages 28 to 05 years and then have been followed from 3 months to 14 years. 
All have been treated long-term with terbutaline and aminophylline. Stereids 
were used variably. 
Results: 1 patient expired due to hemodynami¢ compromise and stereid 
related complications. I patient discontinued aminophylline and terbutaline 
after 11 years of treatment and is without recurrence for the last 3 years. 
Recurrence of attacks were gsually treated with increase in dosage of 
aminophylline and terbutaline. We were able to obtain theophylline levels 
in at least 2 patients during and after the recurrences+ These were noted 
to be sub-therapeutic despite compliance and were probably secondary to 
tanhyphylaxis. Higher doses were effective. 
Conclusions: Empiric treatment with aminophyltine and terbutatine pre- 
vents severe and fatal attacks. Recurrences due tO sub-therapeutic levels 
and tachyphylaxis are effectively treated with increases in doses. 
HYPERTENSION 
~ L e f t  Ventricular Function and Remodel ing in Stage 
I Hypertension: The Treatment of Mild 
Hypertension Study 
Philip R. Liebson, Sinda Dianzumba, Greg Grandits, Ronald J. Prineas, 
Richard H. Grimm, Jr for the TOMHS Reseamh Group. Rush Medical 
Col~age, Chicago, IL; Univemity of Minnesota, Minneapolis, MN 
Left ventdcular (LV) systolic performance and hemodynamic measures were 
evaluated for various types of LV hypertrophy (LVH) patterns in 844 subjects 
(S) with Stage I hypertension [mean BP 140/91] without heart disease, using 
M-mode echocardiography. LVH was determined using LV mass index >_ 134 
g/n~ for men and >_ 110 g/m 2 for women, A total of 130 had LVH. Catsgodes 
of remodeling with LVH included disproportionate septet hypertrophy (DSH) 
In = 10]: septal/postador wall ratio >__ 1.5; concentric hypertrophy (CH) [n 
= 43]: relative wall thickness (RWT) >_ 0,45; eccentric dilated hypedrephy 
(EDH) [n = 10]: RWT < 0.45 and LV dimension >_. 3+1 cm/m 2 [n = 10]; and 
